These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 74814
1. [Current phytotherapeutic agents in the treatment of prostatic diseases]. Rocchietta S. Minerva Med; 1977 Dec 29; 68(63):4261-4. PubMed ID: 74814 [No Abstract] [Full Text] [Related]
2. [Clinical experimentation with V 1326 in prostatic disorders]. Lange, Muret. Bord Med; 1970 Nov 29; 3(11):2807-8 passim. PubMed ID: 4101700 [No Abstract] [Full Text] [Related]
3. [Treatment of prostatic hypertrophy with eviprostat]. Kubo Y, Inoue S, Ono T, Yasui A. Hinyokika Kiyo; 1966 Dec 29; 12(12):1463-7. PubMed ID: 4167083 [No Abstract] [Full Text] [Related]
4. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis. Sugimoto M, Oka M, Tsunemori H, Yamashita M, Kakehi Y. Prostate; 2011 Mar 01; 71(4):438-44. PubMed ID: 21254154 [Abstract] [Full Text] [Related]
5. Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis. Steenkamp V, Gouws MC, Gulumian M, Elgorashi EE, van Staden J. J Ethnopharmacol; 2006 Jan 03; 103(1):71-5. PubMed ID: 16122891 [Abstract] [Full Text] [Related]
6. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis]. Seregin SP, Bratchikov OI, Konoplia AI, Shestakov SG, Dolzhenkov SD, Novikov AV, Shatokhin MN, Kotov AV. Urologiia; 2002 Jan 03; (4):14-6. PubMed ID: 12357892 [Abstract] [Full Text] [Related]
7. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy]. Aliaev IuG, Vinarov AZ, Lokshin KL, Spivak LG. Urologiia; 2007 Jan 03; (2):80-2. PubMed ID: 17578203 [No Abstract] [Full Text] [Related]
8. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia. Fitzpatrick JM, Lynch TH. Urol Clin North Am; 1995 May 03; 22(2):407-12. PubMed ID: 7539185 [Abstract] [Full Text] [Related]
9. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis]. Shaplygin LV, Sivakov AA. Urologiia; 2007 May 03; (3):35-7, 39. PubMed ID: 17722618 [Abstract] [Full Text] [Related]
10. [Application of saw palmetto fruit extract in the treatment of prostate diseases]. Zhan XX, Shang XJ, Huang YF. Zhonghua Nan Ke Xue; 2015 Sep 03; 21(9):841-6. PubMed ID: 26552220 [Abstract] [Full Text] [Related]
11. [Conservative therapy of prostatic complex]. Hammer O. Z Allgemeinmed; 1970 Dec 10; 46(34):1720-1. PubMed ID: 5534545 [No Abstract] [Full Text] [Related]
12. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate. Oka M, Ueda M, Oyama T, Kyotani J, Tanaka M. Prostate; 2009 Sep 15; 69(13):1404-10. PubMed ID: 19489033 [Abstract] [Full Text] [Related]
13. Herbal medications in the treatment of benign prostatic hyperplasia (BPH). Fagelman E, Lowe FC. Urol Clin North Am; 2002 Feb 15; 29(1):23-9, vii. PubMed ID: 12109350 [Abstract] [Full Text] [Related]
14. [The weak site of the stronger sex. Phytotherapy often helps the prostate patient]. MMW Fortschr Med; 1999 Oct 14; 141(41):70. PubMed ID: 10904649 [No Abstract] [Full Text] [Related]
15. [Clinical evaluation of Prosta-caps]. Weiser. Dtsch Med J; 1972 Feb 10; 23(2):155-6. PubMed ID: 4111749 [No Abstract] [Full Text] [Related]
16. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study]. Dörner G, Fritsche C. ZFA (Stuttgart); 1982 Jan 31; 58(3):167-9. PubMed ID: 6176081 [No Abstract] [Full Text] [Related]
18. [Drug therapy of benign prostatic hyperplasia. Pumpkin et al. in the front line]. MMW Fortschr Med; 2000 Jul 27; 142(30):53. PubMed ID: 10955026 [No Abstract] [Full Text] [Related]
19. Botulinum-A toxin: an exciting new treatment option for prostatic disease. Thomas CA, Guercini F, Chuang YC, Chancellor MB. Int J Clin Pract Suppl; 2006 Dec 27; (151):33-7. PubMed ID: 17169009 [Abstract] [Full Text] [Related]
20. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules]. Hallwachs O. MMW Munch Med Wochenschr; 1981 Oct 30; 123(44):1675-6. PubMed ID: 6171728 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]